Ana Vivancos - Publications, H-index & Citations

Ana Vivancos

Vall d'Hebron Barcelona Hospital Campus

49H指数

572论文数

1.0W被引数

收录论文 161

发表时间

Fibroblastic aspartoacylase suppresses TGFβ-mediated responses and cancer progression 成纤维细胞样天冬氨酸酰酶抑制TGFβ介导的反应和癌症进展

Nature Communications

IF15.7

2026-06-16

OAAI

Ianire Astobiza; Catalina Capó-Serra; Cristina Viera; Javier Rodríguez; Patricia Carnicero; Miguel Juliá; Ainara Martinez; Carmen Pérez-López; María Subijana; Carolina Ortiz-Sanz; Saioa Garcia-Longarte; Isabel Mendizabal; Emily J. Kay; Carla Riera-Domingo; Silvia Rivis; Onintza Carlevaris; Leire Egia-Mendikute; Sara Cascais; Natalia Martín-Martín; Sonia Fernandez-Ruiz; Veronica Torrano; Jana R. Crespo; Mikel Pujana-Vaquerizo; Elisa Espinet; Andreas Trumpp; Noemi Eiro; Francisco J. Vizoso; Ana Vivancos; Joan Seoane; David Gonzalo; Sofia Rey; Aida Santos-Martin; Aitziber Ugalde-Olano; Claudia Manini; Jose I. Lopez; Diana Cabrera; Sebastian M. Van Liempd; Juan M. Falcon-Perez; Roger R. Gomis; Asís Palazon; Christian Frezza; Mireia Castillo-Martin; Sara Zanivan; Massimiliano Mazzone; Miguel Unda; Ana Loizaga-Iriarte; Arkaitz Carracedo; Fernando Calvo

Evolving landscape of targeted therapies in early phase clinical trials 靶向疗法在早期临床试验中的演变格局

European Journal of Cancer

IF7.1

2026-04-12

PREAI

Alice Rossi; Irene Braña; Maria Vieito; Oriol Mirallas; Victor Navarro; Omar Saavedra; Guzman Alonso Casal; Vladimir Galvao; M Julia Lostes Bardaji; Arjun Oberoi; Giulia Pretelli; Marta Sanz; Sergio Andres Bueno; Benet Fite Abril; Susana Aguilar Izquierdo; Jose Jimenez; Paolo Nuciforo; Ana Vivancos; Mafalda Oliveira; Iosune Baraibar

Genomic actionability and matched targeted therapy in a decade-long institutional precision medicine program for solid tumors 基因组可操作性及匹配的靶向疗法在为期十年的机构实体瘤精准医学项目中的应用

ESMO Open

IF8.3

2025-11-06

OAAI

R. Dienstmann; A. Vivancos; P. Nuciforo; S. Aguilar; F. Ruiz-Pace; C. Viaplana; J. Gonzalez; B. Fite; A. Pedrola; E. Elez; C. Saura; E. Felip; T. Macarulla; J. Capdevila; L. Fariñas-Madrid; J. Carles; J. Mateo; E. Muñoz-Cosuelo; J. Balmaña; I. Braña; E. Garralda; J. Tabernero

HER2DX in older patients with HER2-positive early breast cancer: extended follow-up from the RESPECT trial of trastuzumab ± chemotherapy HER2DX在HER2阳性早期乳腺癌老年患者中的应用：来自RESPECT试验中曲妥珠单抗±化疗的扩展随访研究

Nature Communications

IF15.7

2025-11-04

OAAI

Kazuki Nozawa; Masataka Sawaki; Yukari Uemura; Michiko Tsuneizumi; Toshimi Takano; Naomi Gondo; Fumikata Hara; Michiko Harao; Tatsuya Toyama; Naruto Taira; Ana Vivancos; Charles M. Perou; Esther Sanfeliu; Fara Brasó-Maristany; Joel S. Parker; Wesley Buckingham; Laia Paré; Guillermo Villacampa; Mercedes Marín-Aguilera; Patricia Villagrasa; Aleix Prat; Hiroji Iwata

Optimizing early-phase immunotherapy trials: the role of biomarker enrichment strategies 优化早期免疫治疗试验：生物标志物富集策略的作用

FRONTIERS IN IMMUNOLOGY

IF5.9

2025-10-22

OAAI

Catani, Greta; Morchon-Araujo, Daniel; Mirallas, Oriol; Sanchez-Perez, Vicky; Nuciforo, Paolo; Villacampa, Guillermo; Dienstmann, Rodrigo; Vivancos, Ana; Garralda, Elena; Hernando-Calvo, Alberto

Efficacy of anti-PD1 therapy in PD1-high mRNA tumors across multiple cancer types: results from cohort 1 and cohort 2 of the phase II SOLTI-1904 ACROPOLI trial PD1疗法在PD1高表达mRNA肿瘤中的疗效：SOLTI-1904 ACROPOLI II期试验中队列1和队列2的结果

ESMO Open

IF8.3

2025-09-30

OAAI

E. Seguí; F. Brasó-Maristany; T. Pascual; E. Sanfeliu; I. Victoria; C. Saura; C. Hierro; A. López-González; Y. Izarzugaza; E. Ciruelos; J. Gavilá; F. Racca; J.M. Cejalvo; K. Amillano; L. Paz-Ares; M. Juan; E. Felip; E. Garralda; B. González; A. Arance; J. Martín-Liberal; B. Conte; B. Walbaum; A. Indacochea; O. Castillo; P. Blasco; F. Pardo; Á. Aguirre; V. Sirenko; X. González; P. Galván; A. Vivancos; J.M. Ferrero-Cafiero; A. Mulero-Sánchez; F. Salvador; G. Villacampa; R. Mesía; A. Cervantes; A. Prat; J. Tabernero

HER2DX and survival outcomes in early-stage HER2-positive breast cancer: an individual patient-level meta-analysis HER2DX和早期HER2阳性乳腺癌的生存结局：一项基于个体患者水平的荟萃分析

lancet oncology

IF0

2025-07-14

PREAI

Guillermo Villacampa; Tomás Pascual; Paolo Tarantino; Javier Cortés; José Perez-García; Antonio Llombart-Cussac; Pierfranco Conte; Mario Mancino; Valentina Guarneri; Maria Vittoria Dieci; Adrienne G Waks; Francesco Schettini; Fara Brasó-Maristany; Gaia Griguolo; Beatriz Alonso de Castro; Cristina Reboredo; Silvia Antolín; Coralia Bueno-Muiño; Isabel Echavarría; Sara López-Tarruella; Tatiana Massarrah; María del Monte-Millán; Miguel Martín; Wesley Buckingham; Joel S Parker; Ana Vivancos; Kornelia Polyak; Otto Metzger Filho; Antonio C Wolff; Angela DeMichele; Nadine M Tung; Charles M Perou; Laia Paré; Patricia Villagrasa; Aleix Prat; Sara M Tolaney

Best practices in sample management and molecular profiling of cholangiocarcinoma: a practical guide 胆管癌样本管理及分子分型的最佳实践：实用指南

Expert Review of Molecular Diagnostics

IF3.6

2025-06-12

OAAI

Florian Castet; Maria Teresa Salcedo; Paolo Nuciforo; Susana Aguilar; Ana Vivancos

Identifying germline pathogenic variants in breast cancer using tumor sequencing 通过肿瘤测序鉴定乳腺癌中的生殖系致病性变异

BREAST

IF7.9

2025-06-01

OAAI

Cruellas, Mara; Papakonstantinou, Andri; Lopez-Fernandez, Adria; Castillo, Ester; Matito, Judit; Gomez, Marina; Rezqallah, Alejandra; Vega, Sharela; Navarro, Victor; Torres, Maite; Moles-Fernandez, Alejandro; Saura, Cristina; Vivancos, Ana; Balmana, Judith; Oliveira, Mafalda

Correlation of the HER2DX Genomic Test withPathologic Features in Early-Stage HER2+BreastCancer

LABORATORY INVESTIGATION

IF4.2

2025-03-01

PREAI

Sanfeliu, Esther; Martinez-Romero, Anabel; Marin-Aguilera, Mercedes; Gonzalez-Farre, Blanca; Galvan, Patricia; Infantes, Angela Aguirre; Alarcon, Valeria Sirenko; Blasco, Paula; Castillo, Oleguer; Hernandez-Illan, Eva; Jares, Pedro; Puig-Butille, Joan Anton; Martinez, Antonio; Munoz, Montserrat; Losada, MariaVidal; Pascual, Tomas; Martinez, Olga; Solis, Elia Segui; Garcia-Fructuoso, Isabel; Cejalvo, Juan Miguel; Ciruelos, Eva; Brunet, Laia Pare; Vivancos, Ana; Villagrasa, Patricia; Buckingham, Wesley; Parker, Joel; Braso-Maristany, Fara; Prat, Aleix

Comprehensive histopathological analysis of gastric cancer in European and Latin America populations reveals differences in PDL1, HER2, p53 and MUC6 expression

GASTRIC CANCER

IF5.1

2025-01-05

OAAI

Martinez-Ciarpaglini, Carolina; Barros, Rita; Caballero, Carmelo; Boggino, Hugo; Alarcon-Molero, Lorena; Peleteiro, Barbara; Ruiz-Garcia, Erika; Fernandez-Figueroa, Edith; Herrera-Goepfert, Roberto; Diaz-Romero, Consuelo; Ferreira, Rui; Groen-van Schooten, Tessa S.; Gauna, Cinthia; Pereira, Rita; Cantero, Daniel; Lezcano, Horacio; Esteso, Federico; O'Connor, Juan; Riquelme, Arnoldo; Owen, Gareth I.; Garrido, Marcelo; Roa, Juan Carlos; Ruiz-Pace, Fiorella; Vivancos, Ana; Diez-Garcia, Marc; Alsina, Maria; Matito, Judit; Martin, Agatha; Gomez, Marina; Castillo, Ester; Vila, Maria; Santos-Antunes, Joao; Costa, Andreia; Lordick, Florian; Farres, Judith; Palomar-De Lucas, Brenda; Cabeza-Segura, Manuel; Villagrasa, Rosanna; Jimenez-Marti, Elena; Miralles-Marco, Ana; Dienstmann, Rodrigo; Derks, Sarah; Figueiredo, Ceu; Cervantes, Andres; Carneiro, Fatima; Fleitas-Kanonnikoff, Tania

Linking tumor immune infiltration to enhanced longevity in recurrence-free breast cancer

ESMO OPEN

IF8.3

2025-01-01

OAAI

Angelats, L.; Pare, L.; Rubio-Perez, C.; Sanfeliu, E.; Gonzalez, A.; Segui, E.; Villacampa, G.; Marin-Aguilera, M.; Pernas, S.; Conte, B.; Albarran-Fernandez, V.; Martinez-Saez, O.; Aguirre, A.; Galvan, P.; Fernandez-Martinez, A.; Cobo, S.; Rey, M.; Martinez-Romero, A.; Walbaum, B.; Schettini, F.; Vidal, M.; Buckingham, W.; Munoz, M.; Adamo, B.; Agrawal, Y.; Guedan, S.; Pascual, T.; Agudo, J.; Grzelak, M.; Borcherding, N.; Heyn, H.; Vivancos, A.; Parker, J. S.; Villagrasa, P.; Perou, C. M.; Prat, A.; Braso-Maristany, F.

Post-surgery sequelae unrelated to disease progression and chemotherapy revealed in follow-up of patients with stage III colon cancer III期结肠癌患者随访中发现与疾病进展和化疗无关的术后后遗症

EBIOMEDICINE

IF10.8

2024-10-01

OAAI

Mirandola, Alexia; Kudriavtsev, Andrei; Munoz, Catalina Isabel Cofre; Navarro, Raquel Comas; Macagno, Marco; Daoud, Saidi; Sanchez, Cynthia; Pastor, Brice; Pisareva, Ekaterina; Marin, Mireia Sanchis; Ruiz, Javier Gonzalo; Piris, Alejandro; Rodriguez, Ariadna Garcia; Gonzalez, Nadia Saoudi; Vivancos, Ana; Quara, Virginia; Mellano, Alfredo; Borghi, Felice; Corti, Giorgio; Marchio, Caterina; Sapino, Anna; Bartolini, Alice; Crisafulli, Giovanni; Bardelli, Alberto; Di Maio, Massimo; Lossaint, Gerald; Frayssinoux, Florence; Crapez, Evelyne; Ychou, Marc; Soler, Ramon Salazar; Fenocchio, Elisabetta; Calotti, Paula X. Fernandez; Mazard, Thibault; Vivas, Cristina Santos; Elez, Elena; Di Nicolantonio, Federica; Thierry, Alain R.

Five latent factors underlie response to immunotherapy 免疫疗法反应的五个潜在因素

NATURE GENETICS

IF31.8

2024-09-12

OAAI

Usset, Joseph; Huber, Axel Rosendahl; Andrianova, Maria A.; Batlle, Eduard; Carles, Joan; Cuppen, Edwin; Elez, Elena; Felip, Enriqueta; Gomez-Rey, Marina; Lo Giacco, Deborah; Martinez-Jimenez, Francisco; Munoz-Couselo, Eva; Siu, Lillian L.; Tabernero, Josep; Vivancos, Ana; Muinos, Ferran; Gonzalez-Perez, Abel; Lopez-Bigas, Nuria

Pan-cancer homologous recombination deficiency (HRD) evaluation in patients enrolled in a routine molecular screening program 泛癌种同源重组缺陷（HRD）在参与常规分子筛查项目的患者中的评估

ANNALS OF ONCOLOGY

IF65.4

2024-09-01

PREAI

Romero-Lozano, P.; Hernando Calvo, A.; Castillo, E.; Lo Giacco, D. G.; Vila-Casadesus, M.; Gomez, M.; Buono, G.; Bach, V.; Pereira, M.; Onieva, A.; Martin, A.; Matito, J.; Nuciforo, P. G.; Garralda, E.; Felip, E.; Saura Manich, C.; Galceran, J. C.; Garcia Duran, C.; Tabernero, J.; Vivancos, A.

A Phase II, Open-Label, Randomized Trial of Durvalumab With Olaparib or Cediranib in Patients With Mismatch Repair-Proficient Colorectal or Pancreatic Cancer

CLINICAL COLORECTAL CANCER

IF3.2

2024-09-01

PREAI

Hernando-Calvo, Alberto; Han, Ming; Ayodele, Olubukola; Wang, Ben X.; Bruce, Jeffrey P.; Abbas-Aghababazadeh, Farnoosh; Vila-Casadesus, Maria; Sanz-Garcia, Enrique; Yang, S. Y. Cindy; Berman, Hal K.; Vivancos, Ana; Lam, Bernard; Lungu, Ilinca; Salawu, Abdulazeez; Stayner, Lee-Anne; Haibe-Kains, Benjamin; Bedard, Philippe L.; Avery, Lisa; Razak, Albiruni R. A.; Pugh, Trevor J.; Spreafico, Anna; Siu, Lillian L.; Hansen, Aaron R.

Patritumab deruxtecan in HER2-negative breast cancer: part B results of the window-of-opportunity SOLTI-1805 TOT-HER3 trial and biological determinants of early response

NATURE COMMUNICATIONS

IF15.7

2024-07-11

OAAI

Braso-Maristany, Fara; Ferrero-Cafiero, Juan Manuel; Falato, Claudette; Martinez-Saez, Olga; Cejalvo, Juan Miguel; Margeli, Mireia; Tolosa, Pablo; Salvador-Bofill, Francisco Javier; Cruz, Josefina; Gonzalez-Farre, Blanca; Sanfeliu, Esther; Odena, Andreu; Serra, Violeta; Pardo, Francisco; Luna Barrera, Ana Maria; Arumi, Miriam; Guerra, Juan Antonio; Villacampa, Guillermo; Sanchez-Bayona, Rodrigo; Ciruelos, Eva; Espinosa-Bravo, Martin; Izarzugaza, Yann; Galvan, Patricia; Matito, Judith; Pernas, Sonia; Vidal, Maria; Santhanagopal, Anu; Sellami, Dalila; Esker, Stephen; Fan, Pang-Dian; Suto, Fumitaka; Vivancos, Ana; Pascual, Tomas; Prat, Aleix; Oliveira, Mafalda

Use of ctDNA in early breast cancer: analytical validity and clinical potential

NPJ BREAST CANCER

IF7.6

2024-06-19

OAAI

Panet, Francois; Papakonstantinou, Andri; Borrell, Maria; Vivancos, Joan; Vivancos, Ana; Oliveira, Mafalda

Circulating tumour DNA (ctDNA) as a prognostic biomarker in patients (pts) with refractory metastatic colorectal cancer (mCRC) receiving TAS102 with or without bevacizumab 循环肿瘤DNA (ctDNA) 作为接受TAS102加或不加贝伐单抗治疗的难治性转移性结直肠癌 (mCRC) 患者 (pts) 的预后生物标志物

ANNALS OF ONCOLOGY

IF65.4

2024-06-01

PREAI

Saoudi Gonzalez, N.; Navarro Garces, V.; Salva Ballabrera, F.; Ros Montana, F. J.; Baraibar Argota, I.; Rodriguez Castells, M.; Vaghi, C.; Garcia Rodriguez, A.; Alcaraz, A.; Comas, R.; Dienstmann, R.; Tabernero, J.; Vivancos, A.; Elez Fernandez, M. E.

Homologous-recombination deficiency (HRD) in gastroesophageal adenocarcinoma (GEA): Clinical and molecular features

ANNALS OF ONCOLOGY

IF65.4

2024-06-01

PREAI

Acosta Eyzaguirre, D.; Castillo, G.; Aguilar Izquierdo, S.; Cruellas Lapena, M.; Herencia Ropero, A.; Landolfi, S.; Palma, H.; Tian, T.; Vivancos, A.; Serra Elizalde, V.; Macarulla Mercade, T.

研究方向